ApoCell Awarded Contract to Develop Circulating Tumor Cell Isolation Technology (ApoStreamTM) from NCI's Division of Cancer Treatment and Diagnosis (DCTD)
ApoCell Launches Revolutionary Circulating Cancer Cell Detection System - ApoStreamTM
ApoCell Awarded $2.9M from SAIC-Frederick, Inc. to Deliver a New Platform for Detection and Molecular Analysis of Circulating Tumor Cells
ApoCell named to Inc Magazine's List of the 5000 Fastest Growing Private Companies
ApoCell named to Houston Business Journal's List of the 100 Fastest-Growing Private Companies in Houston
ApoCell awarded SBIR Grant to Develop Point of Care Device for Antibody Independent Isolation of Circulating Tumor Cells
If your need does not map to selections above, please describe in the box provided or contact Biomarkers@apocell.com. Communication via this form is secure and encrypted.